Defective Protein Folding and Aggregation as the Basis of Neurodegenerative Diseases: The Darker Aspect of Proteins

  title={Defective Protein Folding and Aggregation as the Basis of Neurodegenerative Diseases: The Darker Aspect of Proteins},
  author={Aabgeena Naeem and Naveed Ahmad Fazili},
  journal={Cell Biochemistry and Biophysics},
The ability of a polypeptide to fold into a unique, functional, and three-dimensional structure depends on the intrinsic properties of the amino acid sequence, function of the molecular chaperones, proteins, and enzymes. Every polypeptide has a finite tendency to misfold and this forms the darker side of the protein world. Partially folded and misfolded proteins that escape the cellular quality control mechanism have the high tendency to form inter-molecular hydrogen bonding between the same… 
Protein Folding and Misfolding: A Perspective from Theory
This review will stimulate further research in this area and catalyze increased collaboration at the interface of chemistry and biology to decipher the mechanisms and roles of protein folding, misfolding and aggregation in the fields of health and disease.
Snl1 is unique among the cytosolic NEFs as it is localized at the ER membrane with its Hsp70 binding (BAG) domain exposed to the cytOSol, and it is discovered that Snl1 distinctly interacts with assembled.
Deciphering Structural Intermediates and Genotoxic Fibrillar Aggregates of Albumins: A Molecular Mechanism Underlying for Degenerative Diseases
The effect of acetonitrile (ACN) on the conformational stability of HSA and by comparison, ovalbumin (OVA) has been evaluated in the presence and absence of NaCl.
Kinetic trapping in protein folding.
It is proposed that kinetic trapping serves an important role in biology by protecting the bioactive states of a large number of proteins from deleterious aggregation, as long as one considers an extended chemical-potential landscape encompassing aggregates, in addition to native, unfolded and intermediate states.
Modulation in the conformational and stability attributes of the Alzheimer’s disease associated amyloid-beta mutants and their favorable stabilization by curcumin: molecular dynamics simulation analysis
This is the first report on the effect of curcumin binding on structural landscapes of the two contrasting point mutants providing an understanding of the basis of Aβ plaque formation and its prevention byCurcumin.
Protein misfolding in the late‐onset neurodegenerative diseases: Common themes and the unique case of amyotrophic lateral sclerosis
Past studies exploring the stability, folding, and misfolding behavior of SOD1 are discussed, as well as the therapeutic possibilities of using detailed knowledge of misfolded pathways to target the molecular mechanisms underlying ALS and other neurodegenerative diseases.
Molecular mechanisms of disease-causing missense mutations.
Deciphering aggregates, prefibrillar oligomers and protofibrils of cytochrome c
Abstract Aggregation of protein into insoluble intracellular complexes and inclusion bodies underlies the pathogenesis of human neurodegenerative diseases. Importance of cytochrome c (cyt c) arises


The structural basis of protein folding and its links with human disease.
  • C. Dobson
  • Biology
    Philosophical transactions of the Royal Society of London. Series B, Biological sciences
  • 2001
Evidence is accumulating that the formation of the highly organized amyloid aggregates is a generic property of polypeptides, and not simply a feature of the few proteins associated with recognized pathological conditions.
Protein folding and aggregation in bacteria
Overall, this review illustrates how prokaryotic organisms might provide the bedrock on which to understand the complexity of protein folding and aggregation in the cell.
Protein misfolding, functional amyloid, and human disease.
The relative importance of the common main-chain and side-chain interactions in determining the propensities of proteins to aggregate is discussed and some of the evidence that the oligomeric fibril precursors are the primary origins of pathological behavior is described.
Molecular chaperones as modulators of polyglutamine protein aggregation and toxicity
It is suggested that an imbalance between the neuronal chaperone capacity and the production of potentially dangerous polyQ proteins may trigger the onset of polyQ disease.
Crystallin proteins and amyloid fibrils
The ability of sHsps to prevent fibril formation, their mechanisms of action and the possible in vivo consequences of such associations are discussed, along with the potential use of fibrillar crystallin proteins as bionanomaterials.
Intrinsic disorder in proteins associated with neurodegenerative diseases.
The major goals of this review are to show the interconnections between intrinsic disorder and human neurodegenerative diseases and to overview a recent progress in development of novel nanoimaging tools to follow protein aggregation.
Protein aggregation and neurodegenerative disease
There is increased understanding of the pathways involved in protein aggregation, and some recent clues have emerged as to the molecular mechanisms of cellular toxicity, leading to approaches toward rational therapeutics.
Cell death: protein misfolding and neurodegenerative diseases
Evidence is presented suggesting that NO contributes to protein misfolding via S-nitrosylating protein-disulfide isomerase or the E3 ubiquitin ligase parkin, and how memantine/NitroMemantine can inhibit excessive NMDA receptor activity to ameliorate NO production, protein misolding, and neurodegeneration.
Cataract as a conformational disease--the Maillard reaction, alpha-crystallin and chemotherapy.
  • M. Crabbe
  • Biology
    Cellular and molecular biology
  • 1998
Of the many avenues available to block protein aggregation, common analgesics--and vitamin C--may provide a cost-effective route to explore further in the treatment of a range of conformational diseases.